ORBIMED ADVISORS LLC
Top Portfolio Positions
106 positions ·
$5,343,151,020 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| MYGN |
Myriad Genetics Inc
Healthcare
|
125,000,000 | $562,500,000 | 10.53% |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
15,518,492 | $488,832,498 | 9.15% |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
7,959,538 | $312,013,889 | 5.84% |
| RCEL |
AVITA Medical, Inc.
Healthcare
|
82,010,995 | $303,440,681 | 5.68% |
| MDXH |
MDxHealth SA
Healthcare
|
124,306,000 | $285,903,800 | 5.35% |
| LLY |
ELI LILLY & Co
Healthcare
|
236,800 | $217,801,536 | 4.08% |
| BSX |
Boston Scientific Corp
Healthcare
|
2,382,100 | $149,476,775 | 2.80% |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
3,530,702 | $141,545,843 | 2.65% |
| AZN |
Astrazeneca Plc
Healthcare
|
670,200 | $132,176,844 | 2.47% |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
3,637,887 | $108,590,926 | 2.03% |
Portfolio Trend
Holdings in BSX
Shares Held
Position Value (USD)
27 of 27 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $149,476,775 | 2,382,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $230,680,255 | 2,419,300 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $237,172,559 | 2,429,300 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $19,526,000 | 200,000 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $302,165,812 | 2,813,200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $283,795,616 | 2,813,200 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $282,277,996 | 3,160,300 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $274,277,400 | 3,273,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $252,053,730 | 3,273,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $224,167,770 | 3,273,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $191,166,108 | 3,306,800 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $174,599,040 | 3,306,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $182,818,791 | 3,379,900 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $189,613,700 | 3,790,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $180,369,714 | 3,898,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $150,977,286 | 3,898,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $162,851,265 | 4,369,500 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $203,711,855 | 4,599,500 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $235,861,704 | 5,552,300 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $253,119,904 | 5,833,600 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $295,924,856 | 6,920,600 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $10,690,000 | 250,000 | Call | Defined | 2021-08-16 | |
| 2021-03-31 | $267,481,190 | 6,920,600 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $234,501,850 | 6,523,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $185,215,333 | 4,847,300 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $170,188,703 | 4,847,300 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $158,167,399 | 4,847,300 | Shares | Defined | 2020-05-15 | |
| No quarters match your search. | ||||||